• Something wrong with this record ?

RNA-interference screen for p53 regulators unveils a role of WDR75 in ribosome biogenesis

P. Moudry, K. Chroma, S. Bursac, S. Volarevic, J. Bartek

. 2022 ; 29 (3) : 687-696. [pub] 20211005

Language English Country Great Britain

Document type Journal Article

Grant support
20-03457Y Grantová Agentura České Republiky (Grant Agency of the Czech Republic)
R204-A12617-B153 Kræftens Bekæmpelse (Danish Cancer Society)
0060590 Novo Nordisk Fonden (Novo Nordisk Foundation)
DFF-7016-00313 Det Frie Forskningsråd (Danish Council for Independent Research)
R266-2017-4289 Lundbeckfonden (Lundbeck Foundation)
VR-MH 2014-46602-117891-30 Vetenskapsrådet (Swedish Research Council)
170176 Cancerfonden (Swedish Cancer Society)

E-resources Online Full text

NLK Free Medical Journals from 2011
PubMed Central from 2011 to 1 year ago
Europe PubMed Central from 2011 to 1 year ago
ProQuest Central from 2000-01-01 to 1 year ago
Open Access Digital Library from 1997-01-01
Health & Medicine (ProQuest) from 2000-01-01 to 1 year ago

Ribosome biogenesis is an essential, energy demanding process whose deregulation has been implicated in cancer, aging, and neurodegeneration. Ribosome biogenesis is therefore under surveillance of pathways including the p53 tumor suppressor. Here, we first performed a high-content siRNA-based screen of 175 human ribosome biogenesis factors, searching for impact on p53. Knock-down of 4 and 35 of these proteins in U2OS cells reduced and increased p53 abundance, respectively, including p53 accumulation after depletion of BYSL, DDX56, and WDR75, the effects of which were validated in several models. Using complementary approaches including subcellular fractionation, we demonstrate that endogenous human WDR75 is a nucleolar protein and immunofluorescence analysis of ectopic GFP-tagged WDR75 shows relocation to nucleolar caps under chemically induced nucleolar stress, along with several canonical nucleolar proteins. Mechanistically, we show that WDR75 is required for pre-rRNA transcription, through supporting the maintenance of physiological levels of RPA194, a key subunit of the RNA polymerase I. Furthermore, WDR75 depletion activated the RPL5/RPL11-dependent p53 stabilization checkpoint, ultimately leading to impaired proliferation and cellular senescence. These findings reveal a crucial positive role of WDR75 in ribosome biogenesis and provide a resource of human ribosomal factors the malfunction of which affects p53.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22019252
003      
CZ-PrNML
005      
20220804135453.0
007      
ta
008      
220720s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41418-021-00882-0 $2 doi
035    __
$a (PubMed)34611297
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Moudry, Pavel $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic. pavel.moudry@upol.cz $1 https://orcid.org/000000021479007X
245    10
$a RNA-interference screen for p53 regulators unveils a role of WDR75 in ribosome biogenesis / $c P. Moudry, K. Chroma, S. Bursac, S. Volarevic, J. Bartek
520    9_
$a Ribosome biogenesis is an essential, energy demanding process whose deregulation has been implicated in cancer, aging, and neurodegeneration. Ribosome biogenesis is therefore under surveillance of pathways including the p53 tumor suppressor. Here, we first performed a high-content siRNA-based screen of 175 human ribosome biogenesis factors, searching for impact on p53. Knock-down of 4 and 35 of these proteins in U2OS cells reduced and increased p53 abundance, respectively, including p53 accumulation after depletion of BYSL, DDX56, and WDR75, the effects of which were validated in several models. Using complementary approaches including subcellular fractionation, we demonstrate that endogenous human WDR75 is a nucleolar protein and immunofluorescence analysis of ectopic GFP-tagged WDR75 shows relocation to nucleolar caps under chemically induced nucleolar stress, along with several canonical nucleolar proteins. Mechanistically, we show that WDR75 is required for pre-rRNA transcription, through supporting the maintenance of physiological levels of RPA194, a key subunit of the RNA polymerase I. Furthermore, WDR75 depletion activated the RPL5/RPL11-dependent p53 stabilization checkpoint, ultimately leading to impaired proliferation and cellular senescence. These findings reveal a crucial positive role of WDR75 in ribosome biogenesis and provide a resource of human ribosomal factors the malfunction of which affects p53.
650    _2
$a molekuly buněčné adheze $x metabolismus $7 D015815
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a buněčné jadérko $x genetika $x metabolismus $7 D002466
650    _2
$a DEAD-box RNA-helikasy $x metabolismus $7 D053487
650    _2
$a lidé $7 D006801
650    _2
$a jaderné proteiny $x genetika $x metabolismus $7 D009687
650    _2
$a prekurzory RNA $x metabolismus $7 D012322
650    12
$a ribozomální proteiny $x genetika $x metabolismus $7 D012269
650    _2
$a ribozomy $x genetika $x metabolismus $7 D012270
650    _2
$a nádorový supresorový protein p53 $x genetika $x metabolismus $7 D016159
655    _2
$a časopisecké články $7 D016428
700    1_
$a Chroma, Katarina $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic $1 https://orcid.org/0000000301410469
700    1_
$a Bursac, Sladana $u Department of Molecular Medicine and Biotechnology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia $1 https://orcid.org/0000000264783409
700    1_
$a Volarevic, Sinisa $u Department of Molecular Medicine and Biotechnology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia $1 https://orcid.org/000000034893389X
700    1_
$a Bartek, Jiri $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic. jb@cancer.dk $u Genome Integrity, Danish Cancer Society Research Center, Copenhagen, Denmark. jb@cancer.dk $u Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Science for Life Laboratory, Karolinska Institute, Stockholm, Sweden. jb@cancer.dk $1 https://orcid.org/0000000320137525 $7 xx0046271
773    0_
$w MED00005364 $t Cell death and differentiation $x 1476-5403 $g Roč. 29, č. 3 (2022), s. 687-696
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34611297 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135447 $b ABA008
999    __
$a ok $b bmc $g 1822726 $s 1170495
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 29 $c 3 $d 687-696 $e 20211005 $i 1476-5403 $m Cell death and differentiation $n Cell Death Differ $x MED00005364
GRA    __
$a 20-03457Y $p Grantová Agentura České Republiky (Grant Agency of the Czech Republic)
GRA    __
$a R204-A12617-B153 $p Kræftens Bekæmpelse (Danish Cancer Society)
GRA    __
$a 0060590 $p Novo Nordisk Fonden (Novo Nordisk Foundation)
GRA    __
$a DFF-7016-00313 $p Det Frie Forskningsråd (Danish Council for Independent Research)
GRA    __
$a R266-2017-4289 $p Lundbeckfonden (Lundbeck Foundation)
GRA    __
$a VR-MH 2014-46602-117891-30 $p Vetenskapsrådet (Swedish Research Council)
GRA    __
$a 170176 $p Cancerfonden (Swedish Cancer Society)
LZP    __
$a Pubmed-20220720

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...